Researchers from the University of Latvia and Riga Technical University have developed a device that, due to its small size and ease of use, will be convenient to use in doctors' offices for early diagnosis of skin melanoma and other types of cancer (basal cell cancer, squamous cell cancer), postoperative scar monitoring and timely recognition of tumour relapse.
- 16 May 2024
The device can save lives. For example, if skin melanoma are detected at an early stage, the survival chance of the patient is almost 100%, whereas the chance is less than 5% if they are detected at one of the last stages. Beating cancer is one of the priorities of the European Health Union.
85% percent of the €645.000 total project costs have been co-financed by the EU's Cohesion Policy.